Affichage 1 à 2 des 2 essais cliniques
|
ESSAI CLINIQUE No essai ClinicalTrials.gov ID |
Investigateur(trice) principal(e)
Coordonnateur(rice) |
||
|---|---|---|---|
|
(EN) A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants With High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma
MK-3475-630/KEYNOTE-630 NCT03833167  Actif en recrutement
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Peau |
Dr Nathaniel Bouganim Paulina Garcia de Alba Graue 514-934-1934 poste 34573 |
|
(EN) A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants With High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma
MK-3475-630/KEYNOTE-630 NCT03833167 Actif en recrutement
|
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
|
Peau |
Dre Mai-Kim Gervais Audrey Lamoureux 514-252-3400 poste 6258 |
Groupe d'étude en oncologie du Québec